PELLEGRINO, SIMONA
PELLEGRINO, SIMONA
Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
Phenotyping severe asthma: a rationale for biologic therapy
2020-01-01 Vatrella, A.; Maglio, A.; Pellegrino, S.; Pelaia, C.; Stellato, C.; Pelaia, G.; Vitale, C.
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
2020-01-01 Maglio, A; Vitale, C; Pellegrino, S; Calabrese, C; Parente, R; Triggiani, M; Stellato, C; Pelaia, C; Pelaia, G; Vatrella, A
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression
2021-01-01 Pelaia, C.; Crimi, C.; Benfante, A.; Caiaffa, M. F.; Calabrese, C.; Carpagnano, G. E.; Ciotta Jnr, D.; D'Amato, M.; Macchia, L.; Nolasco, S.; Pelaia, G.; Pellegrino, S.; Scichilone, N.; Scioscia, G.; Spadaro, G.; Valenti, G.; Vatrella, A.; Crimi, N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phenotyping severe asthma: a rationale for biologic therapy | 1-gen-2020 | Vatrella, A.; Maglio, A.; Pellegrino, S.; Pelaia, C.; Stellato, C.; Pelaia, G.; Vitale, C. | |
| Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy | 1-gen-2020 | Maglio, A; Vitale, C; Pellegrino, S; Calabrese, C; Parente, R; Triggiani, M; Stellato, C; Pelaia, C; Pelaia, G; Vatrella, A | |
| Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression | 1-gen-2021 | Pelaia, C.; Crimi, C.; Benfante, A.; Caiaffa, M. F.; Calabrese, C.; Carpagnano, G. E.; Ciotta Jnr, D.; D'Amato, M.; Macchia, L.; Nolasco, S.; Pelaia, G.; Pellegrino, S.; Scichilone, N.; Scioscia, G.; Spadaro, G.; Valenti, G.; Vatrella, A.; Crimi, N. |